PL448319A1 - Zastosowanie MMP2, jako regulatora różnicowania ludzkich pluripotencjalnych komórek macierzystych w kierunku komórek β trzustki - Google Patents

Zastosowanie MMP2, jako regulatora różnicowania ludzkich pluripotencjalnych komórek macierzystych w kierunku komórek β trzustki

Info

Publication number
PL448319A1
PL448319A1 PL448319A PL44831924A PL448319A1 PL 448319 A1 PL448319 A1 PL 448319A1 PL 448319 A PL448319 A PL 448319A PL 44831924 A PL44831924 A PL 44831924A PL 448319 A1 PL448319 A1 PL 448319A1
Authority
PL
Poland
Prior art keywords
mmp2
regulator
cells
pluripotent stem
human pluripotent
Prior art date
Application number
PL448319A
Other languages
English (en)
Other versions
PL248683B1 (pl
Inventor
Małgorzata BOROWIAK
Katarzyna BŁASZCZYK
Anna Paulina JĘDRZEJAK
Original Assignee
Uniwersytet Im. Adama Mickiewicza W Poznaniu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Im. Adama Mickiewicza W Poznaniu filed Critical Uniwersytet Im. Adama Mickiewicza W Poznaniu
Priority to PL448319A priority Critical patent/PL248683B1/pl
Priority to PCT/IB2025/054019 priority patent/WO2025219914A1/en
Publication of PL448319A1 publication Critical patent/PL448319A1/pl
Publication of PL248683B1 publication Critical patent/PL248683B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0678—Stem cells; Progenitor cells; Precursor cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/73—Hydrolases (EC 3.)
    • C12N2501/734—Proteases (EC 3.4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Przedmiotem zgłoszenia jest zastosowanie MMP2, jako regulatora różnicowania ludzkich pluripotencjalnych komórek macierzystych w kierunku komórek trzustki.
PL448319A 2024-04-16 2024-04-16 Zastosowanie MMP2, jako regulatora różnicowania ludzkich pluripotencjalnych komórek macierzystych w kierunku komórek β trzustki PL248683B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL448319A PL248683B1 (pl) 2024-04-16 2024-04-16 Zastosowanie MMP2, jako regulatora różnicowania ludzkich pluripotencjalnych komórek macierzystych w kierunku komórek β trzustki
PCT/IB2025/054019 WO2025219914A1 (en) 2024-04-16 2025-04-16 A method for increasing proliferation of pancreatic beta-cells using mmp2 and a use of mmp2 as a regulator of differentiation of human pluripotent stem cells towards pancreatic beta-cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL448319A PL248683B1 (pl) 2024-04-16 2024-04-16 Zastosowanie MMP2, jako regulatora różnicowania ludzkich pluripotencjalnych komórek macierzystych w kierunku komórek β trzustki

Publications (2)

Publication Number Publication Date
PL448319A1 true PL448319A1 (pl) 2025-10-20
PL248683B1 PL248683B1 (pl) 2026-01-12

Family

ID=95937567

Family Applications (1)

Application Number Title Priority Date Filing Date
PL448319A PL248683B1 (pl) 2024-04-16 2024-04-16 Zastosowanie MMP2, jako regulatora różnicowania ludzkich pluripotencjalnych komórek macierzystych w kierunku komórek β trzustki

Country Status (2)

Country Link
PL (1) PL248683B1 (pl)
WO (1) WO2025219914A1 (pl)

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
FRANCISCO MIRALLES I IN.,: "The Journal of Cell Biology, 1998, Vol. 143, (3): 827-36.", TGF-B PLAYS A KEY ROLE IN MORPHOGENESIS OF THE PANCREATIC ISLETS OF LANGERHANS BY CONTROLLING THE ACTIVITY OF THE MATRIX METALLOPROTEINASE MMP-2, DOI: 10.1083/jcb.143.3.827 *
KAI KESSENBROCK I IN.,: "Matrix Biology, Vol. 44–46, 2015, pp. 184-190", MATRIX METALLOPROTEINASES IN STEM CELL REGULATION AND CANCER,, DOI: https://doi.org/10.1016/j.matbio.2015.01.022 *
NATHANIEL J. HOGREBE I IN.,: "Nat Biotechnol. 2020 April ; 38(4): 460–470", TARGETING THE CYTOSKELETON TO DIRECT PANCREATIC DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELLS, DOI: 10.1038/s41587-020-0430-6 *
SABINA E. PEREZ I IN.,: "Diabetes. 2005 March ; 54(3): 694–701", MATRIX METALLOPROTEINASES 2 AND 9 ARE DISPENSABLE FOR PANCREATIC ISLET FORMATION AND FUNCTION IN VIVO. *

Also Published As

Publication number Publication date
WO2025219914A1 (en) 2025-10-23
PL248683B1 (pl) 2026-01-12

Similar Documents

Publication Publication Date Title
TWD217340S (zh) 戒指
TWD205495S (zh) 腕錶(一)
TWD212674S (zh) 項鍊
TWD212697S (zh) 項鍊
TWD212693S (zh) 項鍊
CO2021001064A2 (es) Método para la producción de las células t gamma delta
TWD201997S (zh) 手錶
ATE532854T1 (de) Kultivierte zellen aus den langerhansschen inseln
WO2021071289A3 (ko) 줄기세포능을 증대시키기 위한 조성물 및 이의 용도
MX2019009759A (es) Composiciones de peptido estables.
TWD204402S (zh) 手錶
WO2022245977A3 (en) Methods for the expansion of human granulocytemacrophage progenitors and applications thereof
FR3068366B1 (fr) Procede de production de progeniteurs erythroides
AU2020344620A8 (en) Implant comprising first and second sets of pillars for attaching a tendon or ligament to a hard tissue
MX2024010646A (es) Anticuerpos anti-cd39 y uso de los mismos.
DE60110047D1 (de) Zahn-vorläuferzelle und methode für deren herstellung
PL448319A1 (pl) Zastosowanie MMP2, jako regulatora różnicowania ludzkich pluripotencjalnych komórek macierzystych w kierunku komórek β trzustki
MX2020008897A (es) Expansion y diferenciacion de citoblastos.
PL448318A1 (pl) Zastosowanie SPOCK2, jako regulatora różnicowania ludzkich pluripotencjalnych komórek macierzystych w kierunku komórek β trzustki
FR3097557B1 (fr) Nouvel agent de biocontrole et son utilisation pour la lutte contre des maladies fongiques de plantes
TWD206372S (zh) 錶殼
CL2023003613S1 (es) Batería.
CL2021002849A1 (es) Expansión ex-vivo de células t reguladoras humanas libre de perlas
TWD223834S (zh) 瓶子(一)
TWD226377S (zh) 瓶(一)